Pim B Olthof1, Joost Huiskens2, Niek R Schulte3, Dennis A Wicherts3, Marc G Besselink3, Olivier R Busch3, Michal Heger3, Thomas M van Gulik3. 1. Department of Surgery, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. Electronic address: p.b.olthof@amc.nl. 2. Department of Surgery, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; Department of Medical Oncology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. 3. Department of Surgery, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Abstract
BACKGROUND: Transaminase levels are usually measured as markers of hepatocellular injury following liver resection, but recent evidence was unclear on their clinical value. This study aimed to identify factors that determine peak postoperative transaminase levels and correlated transaminase levels to postoperative complications. STUDY DESIGN: All liver resections performed at a single center between 2006 and 2015 were included in the analysis. Multivariate analysis was used to identify factors that determine peak ALT and AST levels and postoperative morbidity and mortality. An ALT and AST cutoff for the prediction of mortality was determined using receiver operating characteristic curves analysis. RESULTS: A total of 539 resections were included. Clavien-Dindo grade III or higher complications, intraoperative transfusion, and operative duration were identified as determinants of peak transaminases. A peak AST cut-off value for predicting mortality was defined at 828 U/L, with an area under the curve of 0.81 (0.73-0.89). The cut-off was an independent predictor of mortality (P < 0.01) along with (intraoperative) transfusion (P < 0.01), fifty-fifty criteria (P < 0.01), and age (P < 0.01). CONCLUSION: Postoperative transaminase levels are independent predictors of postoperative morbidity and mortality and therefore clinically relevant. Transaminase levels usually peak during the first 24 h after surgery and thus possess early prognostic power in terms of postoperative mortality.
BACKGROUND: Transaminase levels are usually measured as markers of hepatocellular injury following liver resection, but recent evidence was unclear on their clinical value. This study aimed to identify factors that determine peak postoperative transaminase levels and correlated transaminase levels to postoperative complications. STUDY DESIGN: All liver resections performed at a single center between 2006 and 2015 were included in the analysis. Multivariate analysis was used to identify factors that determine peak ALT and AST levels and postoperative morbidity and mortality. An ALT and AST cutoff for the prediction of mortality was determined using receiver operating characteristic curves analysis. RESULTS: A total of 539 resections were included. Clavien-Dindo grade III or higher complications, intraoperative transfusion, and operative duration were identified as determinants of peak transaminases. A peak AST cut-off value for predicting mortality was defined at 828 U/L, with an area under the curve of 0.81 (0.73-0.89). The cut-off was an independent predictor of mortality (P < 0.01) along with (intraoperative) transfusion (P < 0.01), fifty-fifty criteria (P < 0.01), and age (P < 0.01). CONCLUSION: Postoperative transaminase levels are independent predictors of postoperative morbidity and mortality and therefore clinically relevant. Transaminase levels usually peak during the first 24 h after surgery and thus possess early prognostic power in terms of postoperative mortality.
Authors: Wouter G van Riel; Rowan F van Golen; Megan J Reiniers; Michal Heger; Thomas M van Gulik Journal: Hepatobiliary Surg Nutr Date: 2016-02 Impact factor: 7.293
Authors: Ivo Giovannini; Carlo Chiarla; Felice Giuliante; Maria Vellone; Francesco Ardito; Gerardo Sarno; Gennaro Nuzzo Journal: Clin Chem Lab Med Date: 2007 Impact factor: 3.694
Authors: Axel Andres; Christian Toso; Bogdan Moldovan; Eduardo Schiffer; Laura Rubbia-Brandt; Sylvain Terraz; Claude E Klopfenstein; Philippe Morel; Pietro Majno; Gilles Mentha Journal: Arch Surg Date: 2011-07-18
Authors: Maartje A J van den Broek; Ronit Shiri-Sverdlov; Joris J W Schreurs; Johanne G Bloemen; Veerle Bieghs; Sander S Rensen; Cornelis H C Dejong; Steven W M Olde Damink Journal: Liver Int Date: 2013-01-29 Impact factor: 5.828
Authors: Michał Grąt; Wacław Hołówko; Zbigniew Lewandowski; Oskar Kornasiewicz; Krzysztof Barski; Michał Skalski; Krzysztof Zieniewicz; Marek Krawczyk Journal: HPB (Oxford) Date: 2012-10-26 Impact factor: 3.647